TLSI — TriSalus Life Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1826667 ·
Last close
$2.17
Market Cap
$134.20M
52W High
$7.95
52W Low
$2.16
ADV30
275,268
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 12,878,000 | 11,095,000 | -7,709,000 | -8,854,000 | 57,562,000 | 41,057,000 | 56,882,000 |
| Jun 2026 | 11,407,000 | 9,899,000 | -9,813,000 | -9,187,000 | 62,448,000 | 46,288,000 | 55,898,000 |
| Mar 2026 | 8,899,000 | 7,669,000 | -8,411,000 | 1,539,000 | 70,979,000 | 56,553,000 | 58,172,000 |
| Dec 2025 | 13,205,000 | 11,443,000 | -3,271,000 | -9,753,000 | 35,331,000 | 20,439,000 | 69,192,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,368,000
Investing CF
$-354,000
Financing CF
$42,742,000
CapEx
$-354,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.49
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-347,085,000
Inventory
$4,638,000
Receivables
$6,126,000
ST Investments
—
EBIT TTM
$-20,305,000
Pretax Income TTM
$-26,243,000
Interest Exp TTM
$5,938,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$46,389,000
EBITDA
$-28,678,000
Free Cash Flow
$-11,607,750
Enterprise Value
$142,562,656
Total Cash
$41,057,000
Total Debt
$33,691,000
Shares Out
61,699,034
Trailing EPS
$-0.41
Book Value
$0.01
ROE
—
ROA
-38.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 45,151,000 | -26,946,000 | -39,227,000 | 35,331,000 | 69,192,000 | -33,861,000 | -18,012,000 |
| Dec 2024 | 29,431,000 | -36,165,000 | -30,045,000 | 23,971,000 | 49,865,000 | -25,894,000 | -40,843,000 |
| Dec 2023 | 18,511,000 | -54,475,000 | -59,363,000 | 24,598,000 | 51,663,000 | -27,065,000 | -50,578,000 |
| Dec 2022 | 12,398,000 | -36,439,000 | -47,187,000 | 21,995,000 | 198,325,000 | -176,330,000 | -32,313,000 |
TTM Snapshot
Revenues TTM
$45,077,000
NetIncome TTM
$-28,212,000
OpCashFlow TTM
—
Assets (Latest)
$62,448,000
Forward EPS
$-0.25
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FOCL | EDAP TMS SA | $133.15M | $2.82 | — |
| PYPD | PolyPid Ltd. | $133.04M | $6.55 | — |
| INGN | Inogen Inc | $140.93M | $5.42 | — |
| KRMD | KORU Medical Systems, Inc. | $149.21M | $3.44 | — |
| LUNG | Pulmonx Corp | $119.33M | $2.74 | — |
News headlines (Yahoo Finance, 1h cache)
TriSalus Life Sciences to Participate in the 38th Annual Piper Sandler Healthcare Conference on December 1, 2026
2026-11-17 21:05 · Yahoo
TriSalus Life Sciences (TLSI) Stock Fair Value Moves Lower After Q3 Miss And Guidance Reset
2026-11-14 12:09 · Yahoo
TriSalus Life Sciences, Inc. Q3 2026 Earnings Call Summary
2026-11-10 22:12 · Yahoo
TriSalus: 3 Key Takeaways for Long-Term Investors
2026-11-10 21:16 · Yahoo
TriSalus (TLSI) Q3 2026 Earnings Call Transcript
2026-11-10 20:49 · Yahoo
TriSalus Life Sciences Q3 Earnings Call Highlights
2026-11-10 19:15 · Yahoo
TriSalus Life Sciences Reports 11.3% Q3 Revenue Growth to $12.9 Million, Revises 2026 Guidance
2026-11-10 15:50 · Yahoo
TriSalus Life Sciences Reports Third Quarter 2026 Results
2026-11-10 13:05 · Yahoo
TriSalus Life Sciences to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
2026-10-29 20:05 · Yahoo
TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
2026-10-20 20:32 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-11-19 16:40:04 | 2026-11-17 | Szela Mary T | CEO, Pres | P - Purchase | 2.46 | 65192 | 160205 |